IGF1R and cancer: Decorin could also target insulin-like growth factor 1 receptor (IGF1R) on the surface of cancer cells and inhibit its downstream signaling or target vascular endothelial growth factor receptor 2 (VEGFR2) on the surface of endothelial cells to promote autophagy [49, 50].